The global Precision Oncology market size in 2023 is 76961.3 million US dollars, and it is expected to be 166972.4 million US dollars by 2030, with a compound annual growth rate of 11.7% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Precision Oncology market include Foundation Medicine (USA), Guardant Health (USA), Illumina, Inc. (USA), Roche Molecular Systems (USA), and Tempus Labs (USA). The share of the top 3 players in the Precision Oncology market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Precision Oncology market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Skin accounted for XX% of Precision Oncology market in 2023. Prostrate share of XX%.
Hospitals accounted for XX% of the Precision Oncology market in 2023. Diagnostic Centers accounts for XX%.
This Precision Oncology market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.
Precision Oncology market country level analysis
The countries covered in the Precision Oncology market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.
Competitive Landscape and Precision Oncology Market Share Analysis
Precision Oncology market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Precision Oncology market.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Precision Oncology industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Precision Oncology market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Precision Oncology market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Precision Oncology market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Precision Oncology business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa
Player list
Foundation Medicine (USA)
Guardant Health (USA)
Illumina, Inc. (USA)
Roche Molecular Systems (USA)
Tempus Labs (USA)
Myriad Genetics (USA)
Personal Genome Life Sciences and Laboratories Inc. (USA)
Exact Sciences Corporation (USA)
Thermo Fisher Scientific Inc. (USA)
Qiagen (Netherlands)
Agilent Technologies (USA)
Types list
Skin
Prostrate
Stomach
Application list
Hospitals
Diagnostic Centers
Table of Content
1 Market Overview
1.1 Precision Oncology Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Precision Oncology Market Size & Forecast
1.4.1 Global Precision Oncology Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Precision Oncology Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Precision Oncology Market Drivers
1.5.2 Precision Oncology Market Restraints
1.5.3 Precision Oncology Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Foundation Medicine (USA)
2.1.1 Business Overview
2.1.2 Foundation Medicine (USA) SWOT Analysis
2.1.3 Foundation Medicine (USA) Precision Oncology Products and Service Offered
2.1.4 Foundation Medicine (USA) Precision Oncology Revenue and Gross Margin
2.2 Guardant Health (USA)
2.2.1 Business Overview
2.2.2 Guardant Health (USA) SWOT Analysis
2.2.3 Guardant Health (USA) Precision Oncology Products and Service Offered
2.2.4 Guardant Health (USA) Precision Oncology Revenue and Gross Margin
2.3 Illumina, Inc. (USA)
2.3.1 Business Overview
2.3.2 Illumina, Inc. (USA) SWOT Analysis
2.3.3 Illumina, Inc. (USA) Precision Oncology Products and Service Offered
2.3.4 Illumina, Inc. (USA) Precision Oncology Revenue and Gross Margin
2.4 Roche Molecular Systems (USA)
2.4.1 Business Overview
2.4.2 Roche Molecular Systems (USA) SWOT Analysis
2.4.3 Roche Molecular Systems (USA) Precision Oncology Products and Service Offered
2.4.4 Roche Molecular Systems (USA) Precision Oncology Revenue and Gross Margin
2.5 Tempus Labs (USA)
2.5.1 Business Overview
2.5.2 Tempus Labs (USA) SWOT Analysis
2.5.3 Tempus Labs (USA) Precision Oncology Products and Service Offered
2.5.4 Tempus Labs (USA) Precision Oncology Revenue and Gross Margin
2.6 Myriad Genetics (USA)
2.6.1 Business Overview
2.6.2 Myriad Genetics (USA) SWOT Analysis
2.6.3 Myriad Genetics (USA) Precision Oncology Products and Service Offered
2.6.4 Myriad Genetics (USA) Precision Oncology Revenue and Gross Margin
2.7 Personal Genome Life Sciences and Laboratories Inc. (USA)
2.7.1 Business Overview
2.7.2 Personal Genome Life Sciences and Laboratories Inc. (USA) SWOT Analysis
2.7.3 Personal Genome Life Sciences and Laboratories Inc. (USA) Precision Oncology Products and Service Offered
2.7.4 Personal Genome Life Sciences and Laboratories Inc. (USA) Precision Oncology Revenue and Gross Margin
2.8 Exact Sciences Corporation (USA)
2.8.1 Business Overview
2.8.2 Exact Sciences Corporation (USA) SWOT Analysis
2.8.3 Exact Sciences Corporation (USA) Precision Oncology Products and Service Offered
2.8.4 Exact Sciences Corporation (USA) Precision Oncology Revenue and Gross Margin
2.9 Thermo Fisher Scientific Inc. (USA)
2.9.1 Business Overview
2.9.2 Thermo Fisher Scientific Inc. (USA) SWOT Analysis
2.9.3 Thermo Fisher Scientific Inc. (USA) Precision Oncology Products and Service Offered
2.9.4 Thermo Fisher Scientific Inc. (USA) Precision Oncology Revenue and Gross Margin
2.10 Qiagen (Netherlands)
2.10.1 Business Overview
2.10.2 Qiagen (Netherlands) SWOT Analysis
2.10.3 Qiagen (Netherlands) Precision Oncology Products and Service Offered
2.10.4 Qiagen (Netherlands) Precision Oncology Revenue and Gross Margin
2.11 Agilent Technologies (USA)
2.11.1 Business Overview
2.11.2 Agilent Technologies (USA) SWOT Analysis
2.11.3 Agilent Technologies (USA) Precision Oncology Products and Service Offered
2.11.4 Agilent Technologies (USA) Precision Oncology Revenue and Gross Margin
3 Global Precision Oncology Market Competition, by Manufacturer
3.1 Global Precision Oncology Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Precision Oncology Players Market Share in 2023
3.2.2 Top 6 Precision Oncology Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Precision Oncology Players Head Office, Business Provided
3.4 Precision Oncology Mergers & Acquisitions
3.5 Precision Oncology New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Precision Oncology Revenue in Value by Type (2019-2030)
4.2 Global Precision Oncology Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Precision Oncology Revenue by Application (2019-2030)
5.2 Global Precision Oncology Revenue Share by Application (2019-2030)
6 Global Precision Oncology Market Analysis by Regions
6.1 Global Precision Oncology Revenue and Market Share by Regions
6.1.1 Global Precision Oncology Revenue by Regions (2019-2030)
6.1.2 Global Precision Oncology Revenue Market Share by Regions (2019-2030)
6.2 North America Precision Oncology Revenue and Growth (2019-2030)
6.3 Europe Precision Oncology Revenue and Growth (2019-2030)
6.4 Asia Pacific Precision Oncology Revenue and Growth (2019-2030)
6.5 South America Precision Oncology Revenue and Growth (2019-2030)
6.6 Middle East and Africa Precision Oncology Revenue and Growth (2019-2030)
7 North America Precision Oncology by Country, by Type, and by Application
7.1 North America Precision Oncology Revenue by Type (2019-2030)
7.2 North America Precision Oncology Revenue by Application (2019-2030)
7.3 North America Precision Oncology Revenue and Market Share by Countries
7.3.1 North America Precision Oncology Revenue in Value by Country (2019-2030)
7.3.2 United States Precision Oncology Revenue and Growth (2019-2030)
7.3.3 Canada Precision Oncology Revenue and Growth (2019-2030)
7.3.4 Mexico Precision Oncology Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Precision Oncology by Country, by Type, and by Application
8.1 Europe Precision Oncology Revenue by Type (2019-2030)
8.2 Europe Precision Oncology Revenue by Application (2019-2030)
8.3 Europe Precision Oncology Revenue and Market Share by Countries
8.3.1 Europe Precision Oncology Revenue in Value by Country (2019-2030)
8.3.2 Germany Precision Oncology Revenue and Growth (2019-2030)
8.3.3 France Precision Oncology Revenue and Growth (2019-2030)
8.3.4 United Kingdom Precision Oncology Revenue and Growth (2019-2030)
8.3.5 Russia Precision Oncology Revenue and Growth (2019-2030)
8.3.6 Italy Precision Oncology Revenue and Growth (2019-2030)
8.3.7 Nordic Precision Oncology Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Precision Oncology by Country, by Type, and by Application
9.1 Asia Pacific Precision Oncology Revenue by Type (2019-2030)
9.2 Asia Pacific Precision Oncology Revenue by Application (2019-2030)
9.3 Asia Pacific Precision Oncology Revenue and Market Share by Countries
9.3.1 Asia Pacific Precision Oncology Revenue in Value by Country (2019-2030)
9.3.2 China Precision Oncology Revenue and Growth (2019-2030)
9.3.3 Japan Precision Oncology Revenue and Growth (2019-2030)
9.3.4 Korea Precision Oncology Revenue and Growth (2019-2030)
9.3.5 India Precision Oncology Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Precision Oncology Revenue and Growth (2019-2030)
9.3.7 Australia Precision Oncology Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Precision Oncology by Country, by Type, and by Application
10.1 South America Precision Oncology Revenue by Type (2019-2030)
10.2 South America Precision Oncology Revenue by Application (2019-2030)
10.3 South America Precision Oncology Revenue and Market Share by Countries
10.3.1 South America Precision Oncology Revenue in Value by Country (2019-2030)
10.3.2 Brazil Precision Oncology Revenue and Growth (2019-2030)
10.3.3 Argentina Precision Oncology Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Precision Oncology by Country, by Type, and by Application
11.1 Middle East & Africa Precision Oncology Revenue by Type (2019-2030)
11.2 Middle East & Africa Precision Oncology Revenue by Application (2019-2030)
11.3 Middle East & Africa Precision Oncology Revenue and Market Share by Countries
11.3.1 Middle East & Africa Precision Oncology Revenue in Value by Country (2019-2030)
11.3.2 Turkey Precision Oncology Revenue and Growth (2019-2030)
11.3.3 Egypt Precision Oncology Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Precision Oncology Revenue and Growth (2019-2030)
11.3.5 UAE Precision Oncology Revenue and Growth (2019-2030)
11.3.6 South Africa Precision Oncology Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Precision Oncology Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Precision Oncology Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer